Task Force I: Direct Cardiovascular Implications of Emerging Infectious Diseases and Biological Terrorism Threats

Journal of the American College of Cardiology

Volumn 49, Issue 12, 2007, Pages 1380-1389

  Baddour, Larry M ^a   Zheng, Zhi Jie ^a   Labarthe, Darwin R ^a   O'Connor, Siobhán ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL WARFARE; BOTULISM; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLOSTRIDIUM BOTULINUM; COXIELLA BURNETII; DISEASE TRANSMISSION; ENDOCARDITIS; ENVIRONMENTAL EXPOSURE; EPIDEMIC; HUMAN; INFECTION; MORBIDITY; MORTALITY; NIPAH VIRUS; NONHUMAN; PRIORITY JOURNAL; Q FEVER; REVIEW; SARS CORONAVIRUS; SMALLPOX VIRUS; SYMPTOMATOLOGY; TULAREMIA;

ADVISORY COMMITTEES; BIOTERRORISM; CARDIOVASCULAR DISEASES; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; HUMANS;

EID: 33947500085     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.01.019     Document Type: Review

References (63)

1. Institute of Medicine. Emerging Infections: Microbial Threats to Health in the United States (1992), National Academy of Science, Washington, DC
2. Rotz L.D., Khan A.S., Lillibridge S.R., et al. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 8 (2002) 225-230
3. Centers for Disease Control and Prevention. Bioterrorism Agents/Diseases by Categories. Available at: http://www.bt.cdc.gov/agent/agentlist-category.asp. Accessed May 17, 2005.
4. Robinson R.F., and Nahata M.C. Management of botulism. Ann Pharmacother 37 (2003) 127-131
5. Raoult D. Marrie T. Q fever. Clin Infect Dis 20 (1995) 489-496
6. Varkey P., Poland G.A., Cockerill III F.R., et al. Confronting bioterrorism: physicians on the front line. Mayo Clin Proc 77 (2002) 661-672
7. Tak T., Dhawan S., Reynolds C., et al. Current diagnosis and treatment of infective endocarditis. Expert Rev Anti Infect Ther 1 (2003) 639-654
8. Durack D.T., Lukes A.S., and Bright D.K. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96 (1994) 200-209
9. Cecchi E., Parrini I., Chinaglia A., et al. New diagnostic criteria for infective endocarditis: a study of sensitivity and specificity. Eur Heart J 18 (1997) 1149-1156
10. Millar B.C., and Moore J.E. Current trends in the molecular diagnosis of infective endocarditis. Eur J Clin Microbiol Infect Dis 23 (2004) 353-365
11. Gore I., and Kline I. Myocarditis. In: Gould S.E. (Ed). Pathology of the Heart and Blood Vessels. 3rd edition (1968), Charles C. Thomas, Springfield, IL 737
12. Wasi F, Shuter J. Primary bacterial infection of the myocardium. Available at: http://www.bioscience.org/2003/v8/s/1021/list.htm. Accessed June 5, 2005.
13. Chinnaiyan K.M., Leff C.B., and Marsalese D.L. Constrictive pericarditis versus restrictive cardiomyopathy: challenges in diagnosis and management. Cardiol Rev 12 (2004) 314-320
14. Maisch B., Seferovic P.M., Ristic A.D., et al. Guidelines on the diagnosis and management of pericardial diseases executive summary: the Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Eur Heart J 25 (2004) 587-610
15. Lie J. Vasculitis associated with infectious agents. Curr Opin Rheumatol 8 (1996) 26-29
16. Mohan N., and Kerr G. Infectious etiology of vasculitis: diagnosis and management. Curr Rheumatol Rep 5 (2003) 136-141
17. Tancik C.A., and Dillaha J.A. Francisella tularensis endocarditis. Clin Infect Dis 30 (2000) 399-400
18. Jager B.V., and Ransmeier J.C. Constrictive pericarditis due to Bacterium tularense: report of a case and review of reported cases of pericarditis occurring with tularemia. Bull Johns Hopkins Hospital 77 (1943) 166
19. Evans M.E., Gregory D.W., Schaffer W., and McGee T.A. Tularemia: a 30-year experience with 88 cases. Medicine 64 (1985) 251-269
20. Reguera J.M., Alarcon A., Miralles F., et al. Brucella endocarditis: clinical, diagnostic, and therapeutic approach. Europ J Clin Microbiol Infect Dis 77 (2003) 647-650
21. Mert A., Kocak F., Ozaras R., et al. The role of antibiotic treatment alone for the management of brucella endocarditis in adults: a case report and literature review. Ann Thorac Cardiovasc Surg 8 (2002) 381-385
22. Peery T.M., and Evans J.M. Brucellosis and heart disease. III. Chronic valvular heart disease following nonfatal brucelloss. Ann Intern Med 49 (1958) 568-579
23. Peery T.M., and Belter L.F. Brucellosis and heart disease. II. Fatal brucelloss: a review of the literature and report of new cases. Am J Path 36 (1960) 673-697
24. Lubani M., Sharda D., and Helin I. Cardiac manifestations in brucellosis. Arch Dis Child 61 (1986) 569-572
25. Aguado J.M., Barros C., Gomez Garces J.L., et al. Infective aortitis due to Brucella melitensis. Scand J Infect Dis 19 (1987) 483-484
26. Erbay A.R., Turham H., Dogan M., et al. Brucella endocarditis complicated with a mycotic aneurysm of the superior mesenteric artery: a case report. Intern J Card 93 (2004) 317-319
27. Ugartemendia M.C., Curos-Abadal A., Pujol-Rakosnik M., et al. Brucella melitensis pericarditis. Am Heart J 109 (1985) 1108
28. Gomez-Huelgas R., de Mora M., Porras J.J., et al. Brucella and acute pericarditis: fortuitous or causal association?. J Infect Dis 154 (1986) 544
29. Blain H., Laraki R., Levy-Soussan M., et al. Aneurysm of thoracic aorta and spondylodiscitis disclosing brucellosis. Rev Med Intern 18 (1997) 876-881
30. Gillet M., Sava P., Cassou M., et al. Infectious aneurysm of the infrarenal aorta. Comments apropos of 2 cases of brucellar etiology. Chirurgie 109 (1983) 168-172
31. Odeh M., and Oliven A. Chlamydial infections of the heart. Europ J Clin Microbiol Infect Dis 11 (1992) 885-893
32. Schinkel A.F.L., Bax J.J., van der Wall E.E., et al. Echocardiographic follow-up of Chlamydia psittaci myocarditis. Chest 117 (2000) 1203-1205
33. Lamaury I., Sotto A., Le Quellec A., et al. Chlamydia psittaci as a cause of lethal bacterial endocarditis. Clin Infect Dis 17 (1993) 821-822
34. Madariaga M.G., Rezai K., Trenholme G.M., et al. Q-fever, a biological weapon in your backyard. Lancet Infect Dis 3 (2003) 709-721
35. Kagawa F.T., Whner J.H., and Mohindra V. Q fever as a biological weapon. Semin Respir Infect 18 (2003) 183-195
36. Maurin M., and Raoult D. Q fever. Clin Microbiol Rev 12 (1999) 528-553
37. Raoult D., Tissot-Dupont H., Foucault C., et al. Q fever 1985-1998: clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore) 79 (2000) 109-123
38. Hoen B., Selton-Suty C., Lacassin T., et al. Infective endocarditis in patients with negative blood cultures: analysis of 88 cases from a one-year nationwide survey in France. Clin Infect Dis 20 (1995) 501-506
39. Fenollar F., Fournier P.E., Carrieri M.P., et al. Risk factors and prevention of Q fever endocarditis. Clin Infect Dis 33 (2001) 312-316
40. Lepidi H., Houpikian P., Liang Z., et al. Cardiac valves in patients with Q-fever endocarditis: microbiological, molecular, and histologic studies. J Infect Dis 187 (2003) 1097-1106
41. Fournier P.E., Etienne J., Harle J.R., et al. Myocarditis, a rare but severe manifestation of Q fever: report of 8 cases and review of the literature. Clin Infect Dis 32 (2001) 1440-1447
42. Pebody R.G., Wall P.G., Ryan M.J., et al. Epidemiological features of Coxiella burnetii infection in England and Wales: 1984 to 1994. Commun Dis Rep CDR Rev 6 (1996) R128-R132
43. Tissot-Dupont H., Raoult D., Brouqui P., et al. Epidemiological features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. Am J Med 93 (1992) 427-434
44. Bautista-Hernandez V., Gutierrez F., Ray V.G., et al. Contrictive pericarditis due to Coxiella burnetii. Ann Thorac Surg 78 (2004) 326-328
45. Lovey P.Y., Morabia A., Bleed D., et al. Long term vascular complications of Coxiella burnetii infection in Switzerland: cohort study. Br Med J 319 (1999) 284-286
46. Ayres J.G., Wildman M., Groves J., et al. Long-term follow-up of patients from the 1989 Q fever outbreak: no evidence of excess cardiac disease in those with fatigue. Q J Med 95 (2002) 539-546
47. Centers for Disease Control and Prevention. Increasing rate of Salmonella enteritidis infections in the northeastern United States. MMWR 36 (1987) 10-11
48. Mead P.S., Slutsker L., Dietz V., et al. Food-related illness and death in the United States. Emerg Infect Dis 5 (1999) 607-625
49. Swartz M. Human disease caused by foodborne pathogens of animal origin. Clin Infect Dis 34 Suppl 3 (2002) S111-S122
50. Holmann E.L. Nontyphiodal salmonellosis. Clin Infect Dis 32 (2001) 263-269
51. Hsu R.B., Tsay Y.G., Chen R.J., et al. Risk factors for primary bacteremia and endovascular infection in patients without acquired immunodeficiency syndrome who have nontyphoid salmonellosis. Clin Infect Dis 36 (2003) 829-834
52. Chiu C.H., and Ou J.T. Risk factors for endovascular infection due to nontyphoid salmonellae. Clin Infect Dis 36 (2003) 835-836
53. Benenson S., Raveh D., Schlesinger Y., et al. The risk of vascular infection in adult patients with nontyphid salmonella bacteremia. Am J Med 110 (2001) 60-63
54. Cohen J.I., Bartlett J.A., and Corey G.R. Extra-intestinal manifestations of samonella infection. Medicine 66 (1987) 349-388
55. Fernandez Guerrero M.L., Aguado J.M., Arribas A., et al. The spectrum of cardiovascular infections due to Salmonella enterica: a review of clinical features and factors determining outcome. Medicine (Baltimore) 83 (2004) 123-138
56. Baysal K., Sancak R., Ozturk F., et al. Cardiac involvement due to Salmonella typhid infections in children. Ann Trop Paediatr 18 (1998) 23-25
57. Wanby P., and Olsen B. Myocarditis in a patient with salmonella and campylobacter enteritis. Scan J Infect Dis 33 (2001) 860-862
58. Ruff M.J., Lamkin Jr. H., Braun J., et al. Melioidosis complicated by pericarditis. Chest 69 (1976) 227-229
59. Majid A.A. Successful surgical management of a case of pulmonary and pericardial melioidosis. Aust N Z J Surg 60 (1990) 139-141
60. Tanyaowalak W., Sunthornyothin S., Luengtaviboon K., et al. Mycotic aneurysm caused by Burkholderia pseudomallei with negative blood cultures. Scand J Infect Dis 36 (2004) 68-70
61. Choonhakarn C., and Jirarattanapochai K. Cutaneous polyarteritis nodosa: a report of a case associated with melioidosis (Burkholderia pseudomallei). Intern J Dermatol 37 (1998) 433
62. Centers for Disease Control and Prevention. Recognitions of illness associated with the intentional release of a biologic agent. MMWR Morb Mortal Wkly Rep 50 (2001) 893-897
63. Centers for Disease Control and Prevention. Recognition of illness associated with exposure to chemical agents-United States, 2003. MMWR Morb Mortal Wkly Rep 52 (2003) 938-940